1. Stocks
  2. Suven Pharmaceuticals Ltd.
  3. Swot
Suven Pharmaceuticals Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Company with Low Debt
Annual Net Profits improving for last 2 years
Company with Zero Promoter Pledge
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Broker downgrades in price or recommendation in the past one month
Decline in Net Profit with falling Profit Margin (QoQ)
Declining Net Cash Flow : Companies not able to generate net cash
High Momentum Scores (Technical Scores greater than 50) 319.5% returns for Nifty 500 over 5.1 years
Highest Recovery from 52 Week Low
Stocks with Expensive Valuations according to the Trendlyne Valuation Score 177.2% returns for Nifty 500 over 4.5 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Expensive Performers (DVM) 79.4% returns for over 5.4 years
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks 187.6% returns for Nifty 500 over 4.5 years
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks 181.7% returns for Nifty 500 over 4.5 years
RSI indicating price weakness
Top Losers